Technology | Radiation Dose Management
September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to ...
September 07, 2017
News | Contrast Media
The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).
September 07, 2017
Feature | Left Atrial Appendage (LAA) Occluders
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to ...
September 07, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | ESC
September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late ...
September 07, 2017
Feature | ESC
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of ...
September 07, 2017
News | Blood Testing
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U.S. Food and Drug Administration (FDA)-cleared high sensitive Elecsys Troponin T Gen 5 blood test (Troponin T Gen 5 or TnT Gen 5) to aid in the diagnosis of heart attacks. The new nine-minute test offers faster answers clinicians can use when diagnosing heart attack.
September 07, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Embolic Protection Devices
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo System is an intra-aortic filter device that deflects embolic material arising during TAVR away from the brain.
September 07, 2017
Technology | Cardiovascular Ultrasound
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens Healthineers that integrates ultrasound and angiography to guide cardiac teams when administering treatment for structural heart disease. Available on the new Release 5.0 of the Acuson SC2000 cardiovascular ultrasound system, TrueFusion is designed to maximize not only interventional cardiology procedures, but also routine diagnosis and follow-up of patients with structural heart disease.
September 06, 2017
News | Heart Failure
September 6, 2017 — Physicians identified a majority of patients with advanced heart failure as at high risk for ...
September 06, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Hypertension
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency department setting to better identify people from central cities with limited access to other venues for medical care.
September 06, 2017
News | Heart Valve Technology
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to evaluate a minimally invasive clip-based repair system made by Abbott for treating people with moderate or severe tricuspid regurgitation (TR). This study is the first application of this minimally invasive technology for use in the tricuspid heart valve, where currently there are no options for most patients. Paul Sorajja, M.D., performed this first-in-human procedure at Minneapolis Heart Institute at Abbott Northwestern Hospital.
September 05, 2017
News | Heart Failure
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company CorAssist in a 72-year-old diastolic heart failure patient.
September 05, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Congenital Heart
Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and effectiveness of a modified version of its Amplatzer device designed to correct patent ductus arteriosus (PDA), a common congenital heart defect.
September 05, 2017
News | Atrial Fibrillation
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with ...
September 01, 2017
News | Atrial Fibrillation
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause ...
September 01, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now